C. Laresche
University of Franche-Comté
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by C. Laresche.
Journal of Investigative Dermatology | 2014
C. Laresche; F. Pelletier; Francine Garnache-Ottou; Thomas Lihoreau; Sabeha Biichle; Guillaume Mourey; Philippe Saas; Philippe Humbert; Estelle Seilles; F. Aubin
Microparticles (MPs) are known to be increased in various malignancies and are involved in tumor invasion, angiogenesis, coagulation, and metastasis. We investigated the plasma levels of annexin-V MPs (AV(+)MPs), platelet-derived MPs (PMPs), and endothelial-derived MPs (EMPs) in patients with melanoma (n=129) and in healthy controls (n=49). A functional coagulation test STA Procoag-PPL measuring the clotting time was performed on samples containing MPs to evaluate their procoagulant potential. The plasma levels of PMPs, EMPs, and AV(+)MPs were significantly higher, and the clotting time-PPL was significantly lower in melanoma patients than in healthy controls. The plasma levels of PMPs, EMPs, and AV(+)MPs were higher in stage IV than in the other stages of melanoma, but with no significant difference. In addition, we observed an inverse correlation between PMPs, AV(+)MPs, and clotting times. Our data suggest that MPs are involved in the progression of melanoma and may be associated to melanoma-associated thrombogenesis.
International Journal of Dermatology | 2014
C. Laresche; Evelyne Fournier; Anne Sophie Dupond; Anne Sophie Woronoff; Christine Drobacheff-Thiebaut; Philippe Humbert; F. Aubin
There are few epidemiological data available on rare skin cancer, including Kaposis sarcoma (KS), which is a multifocal illness affecting the skin, mucosa, and viscera. Four different types of KS have been described: classic, AIDS‐associated, iatrogenic, and African. The purpose of this study was to describe the epidemiology and evolution of the different types of KS in the Doubs region of France.
Experimental Dermatology | 2017
Joséphine Moreau; F. Pelletier; Sabeha Biichle; Guillaume Mourey; Marc Puyraveau; Nicolas Badet; Matthieu Caubet; C. Laresche; Francine Garnache-Ottou; Philippe Saas; Estelle Seilles; F. Aubin
We investigated the plasma levels of PMPs in patients with 45 stage III and 45 stage IV melanoma. PMPs were characterised by flow cytometry and their thrombogenic activity. We also investigated the link between PMPs circulating levels and tumor burden. The circulating levels of PMPs were significantly higher in stage IV (8500 μL−1) than in patients with stage III (2041 μL−1) melanoma (P=.0001). We calculated a highly specific (93.3%) and predictive (91.7%) cut‐off value (5311 μL−1) allowing the distinction between high‐risk stage III and metastatic stage IV melanoma. The thrombogenic activity of PMPs was significantly higher in patients with stage IV melanoma (clotting time: 40.7 second vs 65 second, P=.0001). There was no significant association between the radiological tumoral syndrome and the plasma level of PMPs. Our data suggest the role of PMPs in metastatic progression of melanoma.
Annales De Dermatologie Et De Venereologie | 2013
C. Laresche; E. Fournier; A.-S. Dupond; A.-S. Woronoff; M.-C. Drobacheff-Thiébaut; F. Pelletier; Philippe Humbert; F. Aubin
faite par le DLQI. Il par ailleurs été observé une excellente acceptation du FSFI par les patientes. Conclusion.— Notre étude a permis de mettre en évidence que les patientes atteintes de PV ont une forte altération du bien-être sexuel et principalement celles souffrant de PV cancéreuse et précancéreuse. Il est donc important que ce bien être sexuel puisse être pris en compte au cours d’une consultation de PV. Le FSFI peut répondre à ce besoin car il est un outil largement accepté par les femmes et d’utilisation aisée. Déclaration d’intérêt.— Aucun.
Annales De Dermatologie Et De Venereologie | 2011
C. Laresche; E. Puzenat; S. Penz; E. Plouvier; F. Aubin; Philippe Humbert
P46 Le blueberry muffin baby : à propos de deux cas C. Laresche a,∗, E. Puzenat a, S. Penz a, E. Plouvier b, F. Aubin a,c,d, P. Humbert a,c,e a Dermatologie, CHU, Besançon, France b Hémato-pédiatrie, CHU, Besançon, France c Université de Franche-Comté, Besançon, France d EA3181, IFR133, Besançon, France e Inserm U645, IFR133, Besançon, France Iconographie disponible sur CD et Internet. ∗ Auteur correspondant.
Annales De Dermatologie Et De Venereologie | 2017
A. Fournier; Y.-K. Kaire; B. Roche-Kubler; C. Laresche; A.-S. Dupond
Annales De Dermatologie Et De Venereologie | 2016
A. Fournier; Y.-K. Kaire; B. Roche-Kubler; C. Laresche; A.-S. Dupond
Annales De Dermatologie Et De Venereologie | 2015
A. Fournier; B. Roche-Kubler; C. Laresche; Philippe Humbert; F. Aubin; A.-S. Dupond
Annales De Dermatologie Et De Venereologie | 2014
J. Moreau; A. Thierry-Vuillemin; C. Laresche; F. Pelletier; F. Aubin; I. Boccon-Gibob; A.-S. Dupond
Annales De Dermatologie Et De Venereologie | 2013
C. Laresche; F. Pelletier; Francine Garnache-Ottou; Thomas Lihoreau; Sabeha Biichle; Guillaume Mourey; Philippe Saas; Philippe Humbert; Estelle Seilles; F. Aubin